Pengana Partners with Antipodes to Strengthen Global SMID Investment Strategy
Pengana Capital Group Limited (ASX: PCG) has entered into an agreement with Antipodes Partners Limited to support the management of the investment portfolio of Pengana International Equities Limited (PIA). Under this arrangement, the portfolio will follow the Antipodes Global SMID Strategy, which focuses on investing in attractively valued small- and mid-cap companies listed on major global exchanges. The collaboration is intended to enhance PIA’s investment management approach while maintaining its existing investment mandate and ASX listing.
Antipodes is a recognised global equities investment manager with approximately AU$21 billion in assets under management and investment teams based in Sydney, London, and Melbourne. The firm applies detailed fundamental analysis and disciplined research to identify undervalued opportunities and generate sustainable long-term returns.
The Global SMID Strategy targets companies with market capitalisations between US$1 billion and US$30 billion and has delivered strong performance since its launch. PCG expects the partnership to strengthen portfolio management capabilities and support improved long-term value creation for PIA shareholders.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Pengana Partners with Antipodes to Strengthen Global SMID Investment Strategy
Pengana Capital Group Limited (ASX: PCG) has entered into an agreement with Antipodes Partners Limited to support the management of the investment portfolio of Pengana International Equities Limited (PIA). Under this arrangement, the portfolio will follow the Antipodes Global SMID Strategy, which focuses on investing in attractively valued small- and mid-cap companies listed on major global exchanges. The collaboration is intended to enhance PIA’s investment management approach while maintaining its existing investment mandate and ASX listing.
Antipodes is a recognised global equities investment manager with approximately AU$21 billion in assets under management and investment teams based in Sydney, London, and Melbourne. The firm applies detailed fundamental analysis and disciplined research to identify undervalued opportunities and generate sustainable long-term returns.
The Global SMID Strategy targets companies with market capitalisations between US$1 billion and US$30 billion and has delivered strong performance since its launch. PCG expects the partnership to strengthen portfolio management capabilities and support improved long-term value creation for PIA shareholders.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au